Literature DB >> 7849656

Endocrine responses to overreaching before and after 1 year of weightlifting.

A C Fry1, W J Kraemer, M H Stone, B J Warren, S J Fleck, J T Kearney, S E Gordon.   

Abstract

Nine elite male junior weightlifters (mean age 17.6 +/- 0.3 yrs) performed weightlifting tests before (Test 1) and after (Test 2) 1 week of increased training volume (overreaching) and repeated the protocol after 1 year of their training program. Strength increased by Year 2 (p < 0.05) but did not change during either week of increased training volume. The 1-week overreaching stimulus resulted in attenuated exercise-induced testosterone concentrations during Year 1, but augmented exercise-induced testosterone concentrations during Year 2. Testosterone concentrations at 7 a.m. decreased for only Year 1. For both years, the 1-week overreaching stimulus increased cortisol at 7 a.m, indicative of the increased training volumes. Testosterone/cortisol was not affected by increased training volume for either year. One year of chronic weightlifting and prior exposure to the overreaching stimulus appears to decrease the detrimental effects of stressful training on the endocrine system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7849656     DOI: 10.1139/h94-032

Source DB:  PubMed          Journal:  Can J Appl Physiol        ISSN: 1066-7814


  19 in total

1.  SHBG, plasma, and urinary androgens in weight lifters after a strength training.

Authors:  Marcos Maynar; Rafael Timon; Alfredo González; Guillermo Olcina; Fermin Toribio; Juan I Maynar; Maria J Caballero
Journal:  J Physiol Biochem       Date:  2010-06-09       Impact factor: 4.158

2.  MAPK, androgen, and glucocorticoid receptor phosphorylation following high-frequency resistance exercise non-functional overreaching.

Authors:  Justin X Nicoll; Andrew C Fry; Eric M Mosier; Luke A Olsen; Stephanie A Sontag
Journal:  Eur J Appl Physiol       Date:  2019-08-16       Impact factor: 3.078

Review 3.  Unique aspects of competitive weightlifting: performance, training and physiology.

Authors:  Adam Storey; Heather K Smith
Journal:  Sports Med       Date:  2012-09-01       Impact factor: 11.136

Review 4.  Resistance exercise overtraining and overreaching. Neuroendocrine responses.

Authors:  A C Fry; W J Kraemer
Journal:  Sports Med       Date:  1997-02       Impact factor: 11.136

5.  Authors' Reply to Buckner et al.: 'Comment on: "The General Adaptation Syndrome: A Foundation for the Concept of Periodization".

Authors:  Aaron J Cunanan; Brad H DeWeese; John P Wagle; Kevin M Carroll; Robert Sausaman; W Guy Hornsby; G Gregory Haff; N Travis Triplett; Kyle C Pierce; Michael H Stone
Journal:  Sports Med       Date:  2018-07       Impact factor: 11.136

6.  Increased rate of force development during periodized maximum strength and power training is highly individual.

Authors:  Heikki Peltonen; Simon Walker; Anthony C Hackney; Janne Avela; Keijo Häkkinen
Journal:  Eur J Appl Physiol       Date:  2018-03-06       Impact factor: 3.078

Review 7.  Hormonal responses and adaptations to resistance exercise and training.

Authors:  William J Kraemer; Nicholas A Ratamess
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 8.  Neuroendocrine-immune interactions and responses to exercise.

Authors:  Maren S Fragala; William J Kraemer; Craig R Denegar; Carl M Maresh; Andrea M Mastro; Jeff S Volek
Journal:  Sports Med       Date:  2011-08-01       Impact factor: 11.136

Review 9.  Two emerging concepts for elite athletes: the short-term effects of testosterone and cortisol on the neuromuscular system and the dose-response training role of these endogenous hormones.

Authors:  Blair T Crewther; Christian Cook; Marco Cardinale; Robert P Weatherby; Tim Lowe
Journal:  Sports Med       Date:  2011-02-01       Impact factor: 11.136

10.  Neuromuscular fatigue and potentiation following two successive high intensity resistance exercise sessions.

Authors:  L Z F Chiu; A C Fry; B K Schilling; E J Johnson; L W Weiss
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.